How the hospital room affects recovery

Situation

Hospitals are planned by efficiency parameters. Square metres and bed count drive the investment calculation; hygiene and fire safety decide the permit. The room as a factor on patients and staff does not show up in the planning model.

An evidence base from 2005 to 2025 documents this factor anyway. The pathologist Jeffrey Walch and colleagues compared 89 patients after spine surgery on the bright and the dark sides of the same hospital ward in a 2005 prospective cohort study (Walch et al., 2005, Psychosomatic Medicine 67(1):156-163). The bright side received 46 per cent more sunlight. Patients on the bright side needed 22 per cent fewer analgesics per hour at p=0.047, their analgesic costs ran 21 per cent lower at p=0.047 and reported stress was lower. The design is a prospective cohort, weaker than a randomised trial, and it measures the economically relevant endpoint directly.

The industrial engineer Inas Al Khatib, Samara and Ndiaye published a systematic review of the field in 2024, run on a PRISMA protocol with a bibliometric component (Al Khatib et al., 2024, Frontiers in Built Environment). The search covered literature from 2010 to 2023 on biophilic design in hospitals. The reported associations with shorter length of stay are directionally consistent across the included studies. Postoperative pain demand and staff stress show the same directional consistency, in both cases with methodological heterogeneity in the underlying primary studies. Where the primary studies document effect magnitudes robustly, those magnitudes do not support every marketing claim of the biophilic design industry.

The architecture researcher Bekir Hüseyin Tekin, Corcoran and Urbano Gutiérrez published a meta-synthesis of the qualitative data from the Maggie’s Centres in the UK in 2023 (Tekin et al., 2023, Frontiers of Architectural Research 12(1):188-207). Maggie’s are an institutional special case of cancer-companion architecture. Maggie Keswick Jencks died in 1995. The first centre opened in Edinburgh in 1996. They are house-like buildings with gardens, daylight and domestic rooms, places that cancer patients can visit between treatments.

The landscape architecture researcher ChoHye Youn, Kang and Lee used functional near-infrared spectroscopy in 2025 to measure what happens in the brains of nurses who spend ten minutes in a fully greened room against a white-walled control room (Youn et al., 2025, IJERPH 22(10):1571). Across 21 nurses at a hospital in Cheon-An, South Korea, oxygenation in the dorsolateral prefrontal cortex dropped significantly in the greened room at p<0.001. The sample is small but the measured mechanism is plausible: the brain had less regulation to perform in the quieter setting.

The DRG logic runs across all of this. Across the German case-payment system, comparable European systems and the US Diagnosis-Related-Groups billing, a shorter length of stay translates directly into the cost per case. Staff absence is its own cost factor in the current nursing shortage. Both magnitudes appear in the biophilic literature as outcomes, but no published comparison of DRG case costs exists between biophilically designed and conventionally equipped hospitals.

Finding

The economically translatable effects fall first on postoperative pain demand, which feeds directly into the medication and complication costs inside the case-payment envelope. The length of stay sits next to that on the revenue side of the case payment.

The clearest pain figures come from Walch 2005. The 22 per cent reduction in analgesics per hour and the 21 per cent reduction in analgesic costs both reach p=0.047 in a prospective cohort. Walch measured sun exposure rather than greening or material choice, so the analgesic difference is attributed to daylight; as a prospective cohort the study cannot rule out what else separated the two sides of the ward.

Tekin and colleagues delivered the qualitative validation at an established special case in 2023. Daylight stood at the top for patients in the Maggie’s meta-synthesis, with fresh air and greenery close behind. For staff, privacy and quiet led instead. Patients prioritised these room factors over the strictly medical service of the Centres. This is qualitative evidence, and it still lines up with the economically measurable daylight effect in Walch.

Youn 2025 adds a neurophysiological hint. The drop in dlPFC oxygenation points to reduced cognitive load. Youn measured nurses in a greened setting while Walch measured patients under daylight, so the populations and the interventions differ, and no pathway between them has been demonstrated. What stays plausible is that the brain spends less regulatory capacity in a quieter setting and leaves more room for other processes. The common mechanism is an open research question.

The same architectural feature that lowered dlPFC oxygenation in Youn’s experiment can also bring an infection risk inside a hospital. The infectious-diseases physician Bernard Surial and colleagues measured a vertical green wall in a Swiss hospital in 2021 and documented elevated concentrations of bacteria and fungi in the surrounding air, on the wall surface itself and in the irrigation water that fed the plants, including Aspergillus niger and Aspergillus terreus (Surial et al., 2021, Infection Control & Hospital Epidemiology 43(2):273-275). Their own words: “the elevated concentrations of microorganisms in the air, on the plant wall, and in the water of this vertical garden led the hospital’s infection prevention committee to forego any further indoor plant installations.” The committee dropped further indoor planting after the measurement.

The institutional consequence is a differentiated approach by patient group and location. Sehulster and Chinn set this out for the Centers for Disease Control and Prevention in 2003 in the HICPAC guideline (Sehulster and Chinn, 2003, MMWR Recommendations and Reports 52(RR-10)). Fresh and dried flowers and potted plants are forbidden there in patient areas for immunosuppressed patients as a Category II recommendation. For immunocompetent patients they remain permitted, also as a Category II recommendation.

The evidence on daylight, view and outdoor access is not touched by the Surial finding. It is a different class of intervention with a different risk profile.

In a 2025 perspective paper, the medicinal chemist Grzegorz Bulaj, Forero and Huntsman propose biophilic design in the home as an adjunct to digital therapeutics and what they call “drug + digital” combination therapies (Bulaj et al., 2025, Frontiers in Medicine). The paper has no primary data, and its subject is the patient’s home.

The small sample in Youn 2025 is a limit. 21 nurses are too few to generalise from. And the Al Khatib review, systematic in protocol, still draws on primary studies whose quality varies across the included papers. Correlation and causation are not consistently separable in this material.

My own view is that the evidence base already supports an institutional consequence. Anyone who plans or finances hospitals can take the documented effects as a quantifiable factor in the investment calculation, with the uncertainty marked. An operator can put the same factor on staff load and its downstream cost. Today neither group does this.

Research context

The academic translation of this material into health-economics models is still pending. Al Khatib 2024 delivers the field overview, Tekin 2023 the qualitative validation at the Maggie’s Centres. Youn 2025 adds a first neurophysiological mechanism through the measured dlPFC activity. Walch 2005 and Ulrich 1984 stand alongside them as older but hard anchors.

Roger Ulrich showed in Science in 1984 that postoperative patients in hospital rooms with a view of trees had shorter stays and took less potent analgesics than patients facing a brick wall (Ulrich, 1984, Science 224(4647):420-421). The finding has rarely been directly replicated. It sits at the start of the line in which Walch and the newer work stand.

Several gaps remain open. That comparison has not been published. The existing economic estimates extrapolate savings from length-of-stay reductions. The DRG comparison can be run with existing methods.

A second gap is drug response. I think the room also changes how patients respond to medication. The pharmacologist Cristiano Chiamulera and colleagues named this interaction “ecocebo” in a 2024 narrative review and reported literature suggesting that contact with light, nature and features of interior architecture may enhance the effects of analgesic, anxiolytic and antidepressant drugs (Chiamulera et al., 2024, Neuroscience & Biobehavioral Reviews 161:105648). No randomised trial has tested it in a hospital. There the conjecture rests on two observational findings on analgesic demand: Walch’s under daylight and Ulrich’s with a view of trees.

A third gap concerns the capital market. No major healthcare REIT names biophilic design as an investment criterion in its published reporting.

These findings sit inside an older line. Beatley, Jones and Rainey edited a 2018 overview of the healing-environments debate, “Healthy Environments, Healing Spaces” (University of Virginia Press). Shan Jiang reviewed the Chinese literature on therapeutic landscapes and healing gardens against the Western research in 2014 (Jiang, 2014, Frontiers of Architectural Research 3(2):141-153). The newer empirical work is methodologically denser than the older reviews, but it rests on the same untested assumption that room design shifts recovery.

Implications

For healthcare REITs and private hospital operators. An operator that collects pilot data from its own holdings for two years and benchmarks it against comparison groups has an investment argument by 2028 or 2029. The pilot adds one reporting line, outcomes per building.

The comparison a REIT would need already has a design template. In 2005 Walch and colleagues compared patients already assigned to the bright and dark sides of the same ward (Walch et al., Psychosomatic Medicine), which means a portfolio holding older buildings with uneven daylight distribution can run the same comparison on existing stock. The architecture researcher Mardelle Shepley and colleagues ran a before-after comparison in 2012 that mixed the daylight change with other renovations at the same time (Shepley et al., HERD), and Youn and colleagues surveyed only 21 nurses in 2025, too few to generalise from (IJERPH). A REIT-run pilot answers both objections cheaply: hold the building the same and vary only where the daylight already differs, and run it across enough beds that the sample outgrows Youn’s.

For public hospital trusts. The Walch figures reach 22 per cent on analgesic demand and 21 per cent on analgesic cost, and the Al Khatib corpus and the Maggie’s material point the same way. Many of the individual moves, like window placement and daylight ingress, sit inside the planning envelope already. Direct outdoor access on the recovery side is structurally harder, but it is among the most highly rated factors in the Maggie’s data. The argument belongs in the DRG negotiation. A trust that can demonstrate a measurable effect on length of stay or on analgesic demand brings a measured number into the case-payment argument. The Walch figures allow a first approach, and a house-specific audit has to follow.

The three sources do different jobs in a negotiation. Walch and colleagues reported 22 and 21 per cent figures from a prospective cohort with a p-value attached (Walch et al., 2005, Psychosomatic Medicine); Al Khatib and colleagues reviewed more studies in 2024 and confirmed the same direction, but flagged methodological heterogeneity in the underlying work (Frontiers in Built Environment); Tekin and colleagues collected qualitative data at Maggie’s Centres in 2023, useful for ranking which room features patients value most (Frontiers of Architectural Research). Lead the DRG argument with the Walch number. Use Al Khatib and Tekin to explain why the planning budget should prioritise daylight and outdoor access ahead of other room features.

For nursing organisations and personnel representation. Shepley and colleagues reported in 2012 from a quasi-experimental before-after comparison of two intensive care units in New Hampshire that mean staff absence fell from 38 to 23 hours per person in the new daylight-supplied unit (Shepley et al., 2012, HERD 5(2):46-60). The design is a quasi-experiment, the daylight effect is confounded with other changes between the old and the new ward and the significance is borderline at p=0.05. Even with that caveat, Youn 2025 adds a neurophysiological mechanism in the same direction. The findings belong in pay and structural negotiations on working conditions, including where the architectural competition does not have personnel in view. Absence is a cost line that the daylight unit moved.

Youn and colleagues measured oxygenation in 2025, a different method, a different country and a different outcome than Shepley’s, and still found lower dlPFC oxygenation in a greened setting (Youn et al., 2025, IJERPH). A representation body that names the confound keeps the figure usable when better data arrives.

For the pharmaceutical industry. If the conjecture holds, rooms that differ from one trial site to the next would dilute the drug effect a phase-III study measures. Sponsors can record daylight exposure and visual contact with nature in the study protocol, and the acoustic setting separately, starting with the next protocol. Conclusions about drug response wait for a randomised trial.

Recording daylight exposure and visual contact with nature costs a sponsor little and needs no answer on drug response first. A study sponsor can add both to the next protocol as a hedge against an unmeasured confound.

Correction

29 September 2026. An earlier version credited Grzegorz Bulaj and colleagues (2025) with the hypothesis that biophilic design modulates how patients respond to drugs. Their perspective paper proposes biophilic design in the home as an adjunct to digital therapeutics and “drug + digital” combination therapies, and the report now says so. Chiamulera and colleagues (2024) named the link between environment and drug response in a narrative review, which I have added as a source. The report marks the step from there to drug response in hospitals as my own conjecture, resting on Walch (2005) and Ulrich (1984). The advice to pharmaceutical sponsors keeps recording the room, which can start at once, apart from conclusions about drug response, which wait for a randomised trial.